Heparin, cell adhesion, and pathogenesis of inflammatory bow el disease
- 1 July 1999
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 354 (9172) , 62-65
- https://doi.org/10.1016/s0140-6736(98)09267-8
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Treatment of corticosteroid‐resistant ulcerative colitis with heparin —a report of 16 casesAlimentary Pharmacology & Therapeutics, 1997
- 'Sticky' neutrophils, pathergic arthritis, and response to heparin in pyoderma gangrenosum complicating ulcerative colitis.Gut, 1995
- Growth Factors: New ‘Endogenous Drugs’ for Ulcer HealingScandinavian Journal of Gastroenterology, 1995
- Biology of the Syndecans: A Family of Transmembrane Heparan Sulfate ProteoglycansAnnual Review of Cell Biology, 1992
- PROTEOGLYCANS: STRUCTURES AND INTERACTIONSAnnual Review of Biochemistry, 1991
- Response to heparin in patients with ulcerative colitisThe Lancet, 1991
- Isolation of a heparin-like anticoagulant from the plasma of a patient with metastatic bladder carcinomaBlood, 1989
- Inhibition of leucocyte elastase by heparin and its derivativesBiochemical Journal, 1988
- Glycosaminoglycans and Their Binding to Biological MacromoleculesAnnual Review of Biochemistry, 1978
- Coagulation Studies in Ulcerative Colitis and Crohn's DiseaseGastroenterology, 1975